| Literature DB >> 30255079 |
M N Hoque1, Z C Das1, A N M A Rahman1, M G Haider2, M A Islam3.
Abstract
Staphylococcus aureus is a common causative agent of bovine mastitis in dairy herds worldwide. This study was designed to assess the prevalence of mastitis in cows through screening tests and molecular characterization of Staphylococcus aureus strains. Out of 175 randomly screened cows, mastitis was detected in 50 cows by California Mastitis Test (CMT), and from those mastitic cows, 200 quarter milk samples were collected for subsequent culture and PCR based identification. The herd, cow and quarter level prevalence of mastitis was 73.3, 28.6 and 29.5% respectively, and subclinical mastitis (SCM) was the predominant type in all cases. According to bacteriology the overall prevalence of herd, cow and quarter level Staphylococcus aureus mastitis was 72.7, 74.0 and 62.0%, respectively, and the pathogen was mostly associated with clinical mastitis (CM). Cows breed, parity, daily milk yield, regular teat dipping, and dry cow therapy were significantly associated (P < 0.05) risk factors for mastitis onset. This study identifies 145 Staphylococcus aureus isolates which varied greatly with the categories of mastitis (higher in CM), udder quarter location (highest in right rear quarters), and to a lesser extent in the study areas (P < 0.05). Antimicrobial susceptibility testing revealed that 79.3% Staphylococcus aureus strains were resistant to at least one antimicrobial, 49.0% to two or more antimicrobials, and clinical isolates showed more resistance to all tested antibiotics. The highest resistance rate was found to oxytetracyclin, and no resistance to ceftriaxone and azithromycin. Seven enterotoxin gene profile were detected in the tested isolates, and mecA was found in 20.0% isolates indicating the emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA). The isolates were carrying genes in combination, and were found higher in SCM cases. In this study, plasmids (>23 kb to 2.9 kb) were detected in 70.3% strains, and 54.9% plasmid bearing strains were multiple drug resistant (MDR). Thus, the high prevalence of Staphylococcus aureus mastitis is an important concern for diary industry of Bangladesh since the strains of this pathogen is becoming more resistant to commercially available antimicrobials, and this is an alarming concern for both animal and public health.Entities:
Keywords: Bangladesh; Bovine mastitis; Characterization; Multidrug resistant; Plasmids; Staphylococcus aureus
Year: 2018 PMID: 30255079 PMCID: PMC6147393 DOI: 10.1016/j.ijvsm.2018.03.008
Source DB: PubMed Journal: Int J Vet Sci Med ISSN: 2314-4599
Primer sequences, anticipated product size, and sets of multiplex PCR used in this study for identification of Staphylococcus aureus genes.
| Genes | Forward primers (5′-3′) | Reverse primers (5′-3′) | Product size (bp) | PCR set |
|---|---|---|---|---|
| GCGATTGATGGTGATACGGTT | AGCCAAGCCTTGACGAACTAAAGC | 279 | A | |
| GGTTATCAATGTGCGGGTGG | CGGCACTTTTTTCTCTTCGG | 102 | A | |
| GTATGGTGGTGTAACTGAGC | CCAAATAGTGACGAGTTAGG | 164 | A | |
| sec | AGATGAAGTAGTTGATGTGTATGG | CACACTTTTAGAATCAACCG | 491 | A |
| CCAATAATAGGAGAAAATAAAAG | ATTGGTATTTTTTTTCGTTC | 495 | A | |
| AGGTTTTTTCACAGGTCATCC | CTTTTTTTTCTTCGGTCAATC | 430 | A | |
| GTAGAAATGACTGAACGTCCGATAA | CCAATTCCACATTGTTTCGGTCTAA | 163 | B | |
| ATCATTAGGTAAAATGTCTGGACATGATCCA | GCATCAAGTGTATTGGATAGCAAAAGC | 433 | B | |
| ACCCCTGTTCCCTTATCATC | TTTTCAGTATTTGTAACGCC | 326 | B | |
| ATATCAACGTGAGGGCTCTAGTAC | ATGCAGTCAGCTTCTTACTGCTA | 93 | B | |
| CACACATTACGGATAATGCAAG | TCAACCGAATAGAGTGAACTTATCT | 226 | B |
Nucleotide primers were selected from previously published sequence [12], [22], [46].
Herd and cow-level prevalence of mastitis (clinical and subclinical) in some selected areas of Bangladesh.
| Observation | Overall mastitis | Clinical mastitis No. (%) | Subclinical mastitis No. (%) | |||
|---|---|---|---|---|---|---|
| No. examined | No. positive | Prevalence (%) | 95% Cl | |||
| Herd level | 45 | 33 | 73.3 | 62.4–73.6 | 14 (31.1) | 19 (42.2) |
| Cow level | 175 | 50 | 28.6 | 23.5–36.2 | 19 (38.0) | 31 (62.0) |
| Quarter level | 678 | 200 | 29.5 | 26.1–34.3 | 80 (40.0) | 120 (60.0) |
Herd and cow-level prevalence of Staphylococcus aureus mastitis (clinical and subclinical) in some selected areas of Bangladesh.
| Observation | Overall mastitis caused by | Clinical mastitis No. (%) | Subclinical mastitis No. (%) | |||
|---|---|---|---|---|---|---|
| No. examined | No. positive | Prevalence (%) | 95% Cl | |||
| Herd level | 33 | 24 | 72.7 | 60.1–71.2 | 15 (62.5) | 9 (37.5) |
| Cow level | 50 | 37 | 74.0 | 52.1–66.5 | 22 (59.5) | 15 (40.5) |
| Quarter level | 200 | 124 | 62.0 | 31.4–44.3 | 59 (73.8%) | 65 (54.1) |
Odds ratios (OR) and confidence intervals (CI) of factors having significant effect on Staphylococcus aureus mastitis in dairy cows (Logistic regression model).
| Independent variables | Categories | Incidence of clinical mastitis | Incidence of subclinical mastitis | ||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P-value (χ2) | OR | 95% CI | |||
| Breeds | |||||||
| Local zebu | 0.432a | 48.0, 72.1 | 0.001 | 0.501a | 0.96, 14.2 | 0.005 | |
| Crossbred Friesian | 1.000b | 1.000b | |||||
| Shahiwal cross | 0.561a | 22.7, 74.0 | 0.451a | 24.0, 45.5 | |||
| Red Chittagong | 0.301a | 33.2, 88.5 | 0.506a | 10.1, 50.0 | |||
| Parity | 48.1, 67.9 | ||||||
| 1 to 2 | 0.103a | 19.0, 63.1 | 0.005 | 0.433a | 10.2, 38.2 | 0.007 | |
| 3 to 4 | 0.232a | 34.2, 46.3 | 0.502a | 34.1, 48.0 | |||
| ≥ 4 | 1.003b | 1.003b | |||||
| Body Condition Score (BCS) | |||||||
| ≤2.5 | 0.782a | 1.5, 22.3 | 0.803 | No significant effect | |||
| 3.0 to 3.5 | 0.912a,b | 23.2, 56.3 | |||||
| >3.5 | 1.000b | ||||||
| Farm size | |||||||
| 5 to 10 | 0.782a | 2.4, 33.1 | |||||
| 11 to 15 | 0.912a,b | 17.2, 41.4 | 0.726 | No significant effect | |||
| 16 to 20 | 1.000b | ||||||
| >21 | 1.421c | 1.8, 29.2 | |||||
| Milk Yield (L/day) | |||||||
| 2 to 5 | 0.883a | 23.0, 48.2 | 0.001 | 0.851a | 17.0, 52.3 | 0.003 | |
| 6 to 10 | 1.000a | 1.000a | |||||
| 11 to 15 | 1.401a,b | 7.2, 50.5 | 1.331a,b | 20.5, 63.1 | |||
| >15 | 1.315b | 1.7, 32.5 | 1.220b | 17.2, 54.0 | |||
| Regular practice of teat dipping before and after milking (with antiseptic solutions) | |||||||
| Yes | 0.609a | 44.0, 73.1 | 0.001 | 0.203a | 2.8, 31.2 | 0.005 | |
| No | 1.000b | 0.902b | 6.5, 41.7 | ||||
| Dry cow housing | |||||||
| Free-stall | 0.738a | 39.0, 72.1 | 0.002 | 0.013a | 23.0, 70.0 | 0.050 | |
| In tie-stall barns | 1.001b | 0.701b | |||||
The OR describes the risk for developing both clinical and subclinical mastitis caused by Staphylococcus aureus. a,b,cORs with different letter superscripts are statistically significantly different.
Fig. 1Prevalence of Staphylococcus aureus mastitis (subclinical and clinical) in the study areas (P < 0.05). Values (a & b) differ significantly within the study area according to category of mastitis.
Fig. 2Quarter-wise prevalence of Staphylococcus aureus mastitis (subclinical and clinical) in the study areas (P < 0.05). Values (a & b) within different quarters differ significantly according to category of mastitis.
The overall antimicrobial susceptibility patterns of the Staphylococcus aureus isolates (n = 145) from bovine mastitis (subclinical and clinical mastitis) milk samples.
| Antimicrobials | Resistant breakpoint | No. of resistant isolates (%) from | ||
|---|---|---|---|---|
| Subclinical mastitis milk (n = 85) | Clinical mastitis milk (n = 60) | Total isolates (n = 145) | ||
| Penicillin | ≥0.25 | 11 (12.9) | 5 (8.3) | 16 (11.0) |
| Erythromycin | ≥8 | 5 (5.0) | 7 (11.7) | 12 (8.2) |
| Oxytetracycline | ≥16 | 63 (74.1) | 45 (75.0) | 108 (74.5) |
| Trimethoprim/sulfamethoxazole | ≥8/152 | 29 (34.1) | 15 (25.0) | 44 (30.3) |
| Ciprofloxacin | ≥4 | 43 (50.6) | 29 (48.3) | 72 (49.6) |
| Gentamicin | ≥8 | 12 (14.1) | 14 (23.3) | 26 (17.9) |
| Amoxicillin | ≥0.5 | 33 (38.8) | 28 (33.3) | 61 (42.0) |
| Oxacillin | ≥4 | 47 (55.2) | 34 (56.7) | 81 (55.9) |
| Ceftriaxone | ≥ 2 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Azithromycin | ≥8 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
MICs (µg/mL) determined via disk diffusion and agar dilution methods. The number in the parenthesis indicates the percentage of resistant isolates.
Multidrug resistance (MDR) properties observed among 145 Staphylococcus aureus isolates in bovine mastitis (subclinical and clinical mastitis) milk samples.
| Milk samples (No. of isolates) | No. (%) resistant to indicated number of antimicrobials | |||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | Total resistance (≥1) | |
| Samples from subclinical cases (n = 85) | 5 (5.9) | 17 (20.0) | 11 (12.9) | 20 (23.5) | 7 (8.2) | 60 (70.6) |
| Samples from clinical cases (n = 60) | 9 (15.0) | 13 (21.7) | 18 (30.0) | 15 (25.0) | 0 (0.0) | 55 (91.7) |
| Total samples (n = 145) | 14 (9.7) | 30 (20.7) | 29 (20.0) | 35 (24.1) | 7 (4.8) | 115 (79.3) |
mecA and other toxin gene profile found in Staphylococcus aureus isolates in bovine mastitis (subclinical and clinical) milk samples.
| Toxin gene profiles | Number (%) of | ||
|---|---|---|---|
| Subclinical mastitis milk (n = 85) | Clinical mastitis milk (n = 60) | Total (n = 145) | |
| 16 (18.8) | 13 (21.7) | 29 (20.0) | |
| 5 (5.9) | 1 (1.7) | 6 (4.1) | |
| 7 (8.2) | 3 (5.0) | 10 (6.9) | |
| 3 (3.5) | 1 (1.7) | 4 (2.8) | |
| 7 (8.2) | 1 (1.7) | 8 (5.5) | |
| 6 (7.0) | 2 (3.3) | 8 (5.5) | |
| 11 (12.9) | 0 (0.0) | 11 (7.6) | |
| 5 (5.9) | 1 (1.7) | 6 (4.1) | |
| sec | 9 (10.6) | 4 (6.7) | 13 (9.0) |
| 3 (3.5) | 2 (3.3) | 5 (3.4) | |
| 1 (1.1) | 0 (0.0) | 1 (0.7) | |
| Total | 73 (85.9) | 28 (46.7) | 101 (69.7) |